LBF20207PG26: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:
|LipidBank=XPR1511
|LipidBank=XPR1511
|LipidMaps=LMFA03010026
|LipidMaps=LMFA03010026
|SysName=7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3-oxo-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid
|SysName=7- [ (3R,5S) -Dihydroxy-2R - (3-oxo-1-trans-octenyl)- cyclopentan-1R -yl ] -5-cis-heptenoic acid
|Common Name=&&15-keto Prostaglandin F_2alpha&&
|Common Name=&&15-keto Prostaglandin F_2alpha&&7- [  (3R,5S) -Dihydroxy-2R - (3-oxo-1(E)-octenyl)- cyclopentan-1R -yl ] -5-(Z)-heptenoic acid&&
|Source=15-Keto-prostaglandin F2 alpha  is the oxidized product of prostaglandin F2 alpha  by 15-hydroxyprostaglandin dehydrogenase, which is present in lung, kidney, placenta and other tissues and catalyzes the NAD- or NADP-dependent dehydrogenation of 15-dydroxyl group [[Reference:Hansen_HS:,Prostaglandins,1976,12,647|{{RelationTable/GetFirstAuthor|Reference:Hansen_HS:,Prostaglandins,1976,12,647}}]].
|Source=15-Keto-prostaglandin F2 alpha  is the oxidized product of prostaglandin F2 alpha  by 15-hydroxyprostaglandin dehydrogenase, which is present in lung, kidney, placenta and other tissues and catalyzes the NAD- or NADP-dependent dehydrogenation of 15-dydroxyl group [[Reference:Hansen_HS:,Prostaglandins,1976,12,647|{{RelationTable/GetFirstAuthor|Reference:Hansen_HS:,Prostaglandins,1976,12,647}}]].
|Chemical Synthesis=
|Chemical Synthesis=

Revision as of 11:35, 1 June 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



15-keto Prostaglandin F_2α
LBF20207PG26.png
Structural Information
7- [ (3R,5S) -Dihydroxy-2R - (3-oxo-1-trans-octenyl)- cyclopentan-1R -yl ] -5-cis-heptenoic acid
  • 15-keto Prostaglandin F_2α
  • 7- [ (3R,5S) -Dihydroxy-2R - (3-oxo-1(E)-octenyl)- cyclopentan-1R -yl ] -5-(Z)-heptenoic acid
15-KETO-PGF2α
Formula C20H32O5
Exact Mass 352.224974134
Average Mass 352.46508
SMILES C(CCC(=O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC
Physicochemical Information
15-Keto-prostaglandin F2 alpha is the oxidized product of prostaglandin F2 alpha by 15-hydroxyprostaglandin dehydrogenase, which is present in lung, kidney, placenta and other tissues and catalyzes the NAD- or NADP-dependent dehydrogenation of 15-dydroxyl group Hansen_HS .
15-Keto-prostaglandin F2 alpha is further metabolized by its Delta 13-reduction, beta -oxidation and omega oxidation. The ultimate metabolite is 5 alpha ,7 alpha -dihydroxy-11-keto-tetranorprosta-1,16-dioic acid, and excreted in urine Granstrom_E et al..
It is well known that the biological activities of various prostaglandins are reduced upon their dehydrogenation at carbon-15 by the catalysis of 15-hydroxyprostaglandin dehydrogenase Anggard_E .
cDNA for placental 15-hydroxyprostaglandin dehydrogenase was cloned Ensor_CM et al..
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG26 See above. Anggard_E 1966
n.a. LBF20207PG26 See above. Ensor_CM et al. 1995
n.a. LBF20207PG26 See above. Granstrom_E et al. 1971
n.a. LBF20207PG26 See above. Hansen_HS 1976